An early-phase, dose-escalation study of a hypofractionated approach to concurrent chemoradiation using an an adaptive stereotactic ablative radiotherapy (SABR) boost showed promising results in patients with locally advanced, unresectable non–small cell lung cancer (NSCLC).
Arbor Realty Trust, Inc. (NYSE:ABR – Get Free Report) has been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to […]
A scientific review published Thursday in the American Journal of Primatology disputes information used to determine a faulty conservation status of long-tailed macaques (Macaca fascicularis) the International Union for Conservation of Nature issued.
If ABR closes above $14 on January 19, we will be assigned and earn a total return of $0.70 on $13.30 per share at risk, or 5.26%. Over a 38-day holding period, the annualized return would be 50.6%.
Sabre Co. (NASDAQ:SABR – Get Free Report) saw unusually large options trading on Monday. Investors acquired 70,616 put options on the stock. This is an increase of approximately 1,242% compared to the average daily volume of 5,262 put options. Hedge Funds Weigh In On Sabre Several hedge funds have recently made changes to their positions […]